EN
Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Gilead Sciences (GILD) Valuation Check After Oncology And HIV Therapy Momentum
J.W. Cole Advisors Inc. Purchases 7,397 Shares of Gilead Sciences, Inc. $GILD
Envestnet Asset Management Inc. Lowers Stock Holdings in Gilead Sciences, Inc. $GILD
Envestnet Asset Management Inc. Cuts Stock Holdings in Gilead Sciences, Inc. $GILD - Daily Political
Is Gilead Sciences (GILD) Still Attractive After Strong Multi‑Year Share Price Gains
GILD: Extended HIV And PrEP Strength Will Support Steady Long-Term Earnings Power
Gilead Sciences, Inc. $GILD Stock Holdings Increased by Jones Financial Companies Lllp
ABN AMRO Bank N.V. Acquires Shares of 46,091 Gilead Sciences, Inc. $GILD
Machina Capital S.A.S. Makes New $1.65 Million Investment in Gilead Sciences, Inc. $GILD
Gilead Sciences, Inc. $GILD Shares Purchased by AGF Management Ltd.
Gilead Sciences (GILD) to Release Quarterly Earnings on Tuesday
Principal Financial Group Inc. Trims Holdings in Gilead Sciences, Inc. $GILD
Gilead Sciences Oncology Push Gains Traction With Trodelvy Keytruda Results
Gilead's Growing Oncology Role Reshapes The Investment Case For GILD
Nurix Therapeutics, Inc. (NRIX): A Bull Case Theory - Insider Monkey
Gilead Sciences, Inc. (GILD): A Bull Case Theory
Tailoring targeted therapies for younger women with ER-positive early-stage breast cancer
TIGIT Inhibitors Market Poised for Strong Growth Through 2034, Driven by Expanding Immuno-Oncology Pipeline | DelveInsight
Best Pharmaceutical Stocks To Watch Today - February 1st - Markets Daily
Gilead Sciences (NASDAQ:GILD) Sets New 12-Month High on Analyst Upgrade
Gilead Sciences, Inc. $GILD Position Cut by TD Waterhouse Canada Inc.
Gilead Sciences, Inc. $GILD Stake Lessened by Convergence Investment Partners LLC
Truist Securities Raises Price Target on Gilead Sciences, Inc. (GILD) to $145, Keeps Buy Rating
Top Pharmaceutical Stocks To Add to Your Watchlist - January 31st - Markets Daily
Mediolanum International Funds Ltd Buys 9,971 Shares of Gilead Sciences, Inc. $GILD
Thrivent Financial for Lutherans Boosts Stake in Gilead Sciences, Inc. $GILD
AE Wealth Management LLC Buys 8,554 Shares of Gilead Sciences, Inc. $GILD
UBS Turns More Bullish on Gilead Sciences, Inc. (GILD) Amid Positive Pharma Sector Outlook
Gilead Sciences (NASDAQ:GILD) Price Target Raised to $146.00 at Leerink Partners
10,471 Shares in Gilead Sciences, Inc. $GILD Acquired by Winnow Wealth LLC
Safety and biologic activity of a bispecific T cell receptor targeting HIV Gag in males living with HIV: a first-in-human trial
TD Cowen Forecasts Strong Price Appreciation for Gilead Sciences (NASDAQ:GILD) Stock - Markets Daily
Truist Financial Corp Has $34.45 Million Position in Gilead Sciences, Inc. $GILD - Zolmax
Gilead Sciences (NASDAQ:GILD) CEO Daniel Patrick O'day Sells 10,000 Shares of Stock - Markets Daily
Gilead Sciences (NASDAQ:GILD) Stock Price Expected to Rise, TD Cowen Analyst Says - Stock Observer
Gilead Sciences, Inc. $GILD Holdings Lifted by Foundations Investment Advisors LLC
Patton Albertson Miller Group LLC Purchases Shares of 7,460 Gilead Sciences, Inc. $GILD - Daily Political
Insider Selling: Gilead Sciences (NASDAQ:GILD) CEO Sells 10,000 Shares of Stock
Chronic Hepatitis D Market Poised for Significant Growth During the Forecast Period (2025-2034) as Emerging Therapies Drive Optimism | DelveInsight
Wolfe Research Issues Positive Forecast for Gilead Sciences (NASDAQ:GILD) Stock Price
Ruffer LLP Raises Stake in Gilead Sciences, Inc. $GILD
Mirae Asset Global Investments Co. Ltd. Grows Stake in Gilead Sciences, Inc. $GILD - Markets Daily
Gilead Sciences, Inc. $GILD is AustralianSuper Pty Ltd's 9th Largest Position
New York State Common Retirement Fund Sells 89,400 Shares of Gilead Sciences, Inc. $GILD - Stock Observer
Gilead Sciences (NASDAQ:GILD) Hits New 1-Year High Following Analyst Upgrade - Stock Observer
Federated Hermes Inc. Sells 324,814 Shares of Gilead Sciences, Inc. $GILD
Federated Hermes Inc. Has $294.80 Million Holdings in Gilead Sciences, Inc. $GILD - Daily Political
US Government Targets Major HIV and Arthritis Drugs for Medicare Price Negotiations in 2028, ETPharma
Gilead Sciences (GILD) Is Up 11.0% After Trodelvy Combo Outperforms Keytruda Chemo In Phase 3 Trial - Has The Bull Case Changed?
Gilead's Trodelvy Data Sparks Questions On Valuation And Oncology Growth
Gilead Sciences (NASDAQ:GILD) Price Target Raised to $145.00
Citigroup Increases Gilead Sciences (NASDAQ:GILD) Price Target to $156.00
Gilead Sciences (NASDAQ:GILD) Reaches New 12-Month High Following Analyst Upgrade
Kornitzer Capital Management Inc. KS Reduces Holdings in Gilead Sciences, Inc. $GILD - Daily Political
Top Pharmaceutical Stocks To Keep An Eye On - January 26th - Markets Daily
Gilead Sciences (NASDAQ:GILD) Price Target Raised to $155.00
Gilead Sciences (NASDAQ:GILD) Stock Price Expected to Rise, UBS Group Analyst Says - Zolmax
Gilead Sciences (NASDAQ:GILD) Price Target Raised to $150.00 at BMO Capital Markets
Gilead Sciences, Inc. $GILD Shares Sold by AEGON ASSET MANAGEMENT UK Plc
Gilead Sciences, Inc. $GILD is Sector Gamma AS's 9th Largest Position
AMF Tjanstepension AB Reduces Holdings in Gilead Sciences, Inc. $GILD
Medical Stocks Worth Watching - January 24th - Markets Daily
Mn Services Vermogensbeheer B.V. Acquires 8,500 Shares of Gilead Sciences, Inc. $GILD
Gilead Sciences, Inc. $GILD Shares Sold by Resona Asset Management Co. Ltd.
UniSuper Management Pty Ltd Has $62.38 Million Stake in Gilead Sciences, Inc. $GILD
Gilead Sciences, Inc. $GILD Shares Acquired by Envestnet Portfolio Solutions Inc.
UniSuper Management Pty Ltd Acquires 15,479 Shares of Gilead Sciences, Inc. $GILD - Stock Observer
Teacher Retirement System of Texas Sells 28,085 Shares of Gilead Sciences, Inc. $GILD - Stock Observer
Gilead Sciences (NASDAQ:GILD) Downgraded by Wall Street Zen to Buy
Best Medical Stocks To Keep An Eye On - January 23rd - Markets Daily
MOKAN Wealth Management Inc. Trims Position in Gilead Sciences, Inc. $GILD
Strs Ohio Purchases 24,284 Shares of Gilead Sciences, Inc. $GILD
Rakuten Investment Management Inc. Purchases New Shares in Gilead Sciences, Inc. $GILD - Markets Daily
Top Pharmaceutical Stocks To Watch Now - January 23rd - Daily Political
Grandfield & Dodd LLC Sells 20,655 Shares of Gilead Sciences, Inc. $GILD
Vest Financial LLC Acquires 6,019 Shares of Gilead Sciences, Inc. $GILD - Stock Observer
GILD: Extended HIV Franchise Strength Will Support Stronger Long-Term Earnings Power
CapWealth Advisors LLC Lowers Position in Gilead Sciences, Inc. $GILD
Gilead Sciences (NASDAQ:GILD) Director Jeffrey Bluestone Sells 5,000 Shares - Stock Observer
Analysts Conflicted on These Healthcare Names: Insulet (PODD) and Gilead Sciences (GILD) | Markets Insider
Jeffrey Bluestone Sells 5,000 Shares of Gilead Sciences (NASDAQ:GILD) Stock
Gilead Sciences (NASDAQ:GILD) Reaches New 12-Month High After Analyst Upgrade - Markets Daily
Rothschild & Co Redburn Issues Positive Forecast for Gilead Sciences (NASDAQ:GILD) Stock Price
Gilead Sciences (GILD) Valuation Check After Recent Share Price Softness
Gilead's Yeztugo Approval Highlights HIV Growth And Acquisition-Fueled Upside
Bernstein Remains a Buy on Gilead Sciences (GILD) | Markets Insider
Gilead Sciences, Inc. $GILD Shares Acquired by Wealth Enhancement Advisory Services LLC
Royal Bank Of Canada Forecasts Strong Price Appreciation for Gilead Sciences (NASDAQ:GILD) Stock
Triasima Portfolio Management inc. Grows Position in Gilead Sciences, Inc. $GILD - Daily Political
Tradewinds LLC. Takes $507,000 Position in Gilead Sciences, Inc. $GILD - Markets Daily
Gilead News
Gold price forecast: XAU/USD is above $4,900, is gold market expected to rise?
AI stocks and investment opportunities: What are the best ai stocks to invest in?
